Jeffrey Langsam is Chief Clinical Officer of Oncology Institute, Inc.. Currently has a direct ownership of 57,380 shares of TOI, which is worth approximately $146,892. The most recent transaction as insider was on May 21, 2025, when has been sold 57,380 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 57.4K
n/a 3M change
n/a 12M change
Total Value Held $146,892

Jeffrey Langsam Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 21 2025
BUY
Grant, award, or other acquisition
-
57,380 Added 50.0%
57,380 Common Stock
JL

Jeffrey Langsam

Chief Clinical Officer
Cerritos, CA

Track Institutional and Insider Activities on TOI

Follow Oncology Institute, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TOI shares.

Notify only if

Insider Trading

Get notified when an Oncology Institute, Inc. insider buys or sells TOI shares.

Notify only if

News

Receive news related to Oncology Institute, Inc.

Track Activities on TOI